Ulrike Köhl

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Patrick Hayden, Claire Roddie, Peter Bader et al. · Annals of Oncology · 2021 · 422 citations · Full text

Medicine, Hematology, Oncology +17

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Ibrahim Yakoub‐Agha, Christian Chabannon, Peter Bader et al. · Haematologica · 2019 · 357 citations · Full text

Medicine, Hematology, Oncology +14

Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

Kurt Schönfeld, Christiane Sahm, Congcong Zhang et al. · Molecular Therapy · 2014 · 344 citations · Full text

Life Sciences, Immunology, Oncology +17

CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications

Ulrike Köhl, Stanislava Arsenieva, Astrid Holzinger et al. · Human Gene Therapy · 2018 · 120 citations

Life Sciences, Biotechnology, Immunology +17

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients

Katrin S. Reiners, Maike Sauer, Achim Rothe et al. · Molecular Therapy · 2013 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17